BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asif M. Study of clinically used and recently developed antimycobacterial agents. Orient Pharm Exp Med 2012;12:15-34. [DOI: 10.1007/s13596-011-0020-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Ranasinghe R, Mathai M, Zulli A. Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress. Life Sci 2023;318:121466. [PMID: 36773693 DOI: 10.1016/j.lfs.2023.121466] [Reference Citation Analysis]
2 Alghamdi S, Asif M. Pyrazinamide Analogs Designed for Rational Drug Designing Strategies against Resistant Tuberculosis. Russ J Bioorg Chem 2022;48:491-512. [DOI: 10.1134/s1068162022030037] [Reference Citation Analysis]
3 Alghamdi S, Almehmadi MM, Asif M, Alshehri MM, Kamal M. Antimycobacterial Evaluation and Microwave-Assisted Synthesis of N-(5-methyl-4-oxo-2-arylthiazolidin-3-yl) Isonicotinamide Derivatives. Pharm Chem J. [DOI: 10.1007/s11094-022-02623-0] [Reference Citation Analysis]
4 Alghamdi S, Imran M, Kamal M, Asif M. Synthesis, Characterization and Antimycobacterial Activity of Some Substituted Phenylpyridazinone Derivatives. Pharm Chem J. [DOI: 10.1007/s11094-022-02583-5] [Reference Citation Analysis]
5 Alghamdi S, Asif M. Study of Various Chemically and Structurally Diverse Currently Clinically Used and Recently Developed Antimycobacterial Drugs. Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex 2021. [DOI: 10.5772/intechopen.95538] [Reference Citation Analysis]
6 Asif M, Imran M. Synthesis and Antimycobacterial Activity of 3-(Arylaminomethyl)-5- (Pyridin-4-yl)-1,3,4-Oxadiazole-(3H)-thi-2-One Derivatives Against Mycobacterium Tuberculosis H37rv Strain. CBC 2021;17:261-266. [DOI: 10.2174/1573407216999200507122605] [Reference Citation Analysis]
7 Asif M, Imran M. Antitubercular and Anticonvulsant Activities of Phenyl-di-hydropyridazinone Derivatives Containing 2-Substituted amin-1-yl-methyl and 2-(2-1H-amin-1-yl) ethyl Moieties. Analytical Chemistry Letters 2020;10:414-427. [DOI: 10.1080/22297928.2020.1776633] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Jae Jeong H. A Strategy to Overcome Under-Reporting Issues of Voluntary Medication Error Reporting System, Part II: Changes in Number of Reports by a Counter-error Measure—Computerized Prescriber Order Entry. BBIJ 2017;5. [DOI: 10.15406/bbij.2017.05.00146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Asif M. An Overview on Fluoroquinolone Drugs for the Treatment of Tubercular Infection. IJBSBE 2017;2. [DOI: 10.15406/ijbsbe.2017.02.00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Asif M. Tuberculosis: Treatment-related Problems and Future Facets. Arch Clin Infect Dis 2013;8. [DOI: 10.5812/archcid.14413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]